PL3044331T3 - Sposób diagnostyki hemopatii złośliwych i powiązany zestaw - Google Patents

Sposób diagnostyki hemopatii złośliwych i powiązany zestaw

Info

Publication number
PL3044331T3
PL3044331T3 PL14781927T PL14781927T PL3044331T3 PL 3044331 T3 PL3044331 T3 PL 3044331T3 PL 14781927 T PL14781927 T PL 14781927T PL 14781927 T PL14781927 T PL 14781927T PL 3044331 T3 PL3044331 T3 PL 3044331T3
Authority
PL
Poland
Prior art keywords
hematological malignancies
associated kit
diagnosing hematological
diagnosing
kit
Prior art date
Application number
PL14781927T
Other languages
English (en)
Inventor
Philippe RUMINY
Vinciane MARCHAND
Fabrice JARDIN
Original Assignee
Universite De Rouen
Centre Henri Becquerel
Institut National de la Santé et de la Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite De Rouen, Centre Henri Becquerel, Institut National de la Santé et de la Recherche Médicale filed Critical Universite De Rouen
Publication of PL3044331T3 publication Critical patent/PL3044331T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Testing And Monitoring For Control Systems (AREA)
PL14781927T 2013-09-11 2014-09-11 Sposób diagnostyki hemopatii złośliwych i powiązany zestaw PL3044331T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1358721A FR3010530B1 (fr) 2013-09-11 2013-09-11 Methode de diagnostic des hemopathies malignes et kit associe
PCT/FR2014/052255 WO2015036705A1 (fr) 2013-09-11 2014-09-11 Méthode de diagnostic des hémopathies malignes et kit associé
EP14781927.0A EP3044331B1 (fr) 2013-09-11 2014-09-11 Méthode de diagnostic des hémopathies malignes et kit associé

Publications (1)

Publication Number Publication Date
PL3044331T3 true PL3044331T3 (pl) 2020-10-19

Family

ID=49551641

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14781927T PL3044331T3 (pl) 2013-09-11 2014-09-11 Sposób diagnostyki hemopatii złośliwych i powiązany zestaw

Country Status (11)

Country Link
US (2) US20160319362A1 (pl)
EP (1) EP3044331B1 (pl)
CA (1) CA2923116C (pl)
DK (1) DK3044331T3 (pl)
ES (1) ES2788652T3 (pl)
FR (1) FR3010530B1 (pl)
HR (1) HRP20200747T1 (pl)
HU (1) HUE048794T2 (pl)
PL (1) PL3044331T3 (pl)
PT (1) PT3044331T (pl)
WO (1) WO2015036705A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220290242A1 (en) * 2018-11-05 2022-09-15 Centre Henri Becquerel Method for diagnosing a cancer and associated kit
FR3088077B1 (fr) * 2018-11-05 2023-04-21 Centre Henri Becquerel Methode de diagnostic d'un cancer et kit associe
JP7792329B2 (ja) * 2020-03-31 2025-12-25 島津ダイアグノスティクス株式会社 セレウス菌グループ検出用培地

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2250118C (en) * 1996-03-26 2009-09-29 Michael S. Kopreski Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
EP1130113A1 (en) 2000-02-15 2001-09-05 Johannes Petrus Schouten Multiplex ligation dependent amplification assay
AU2002366179A1 (en) * 2001-11-20 2003-06-10 The Regents Of The University Of California Early leukemia diagnostics using microsphere arrays
WO2006017942A1 (en) * 2004-08-20 2006-02-23 University Of Manitoba Methods of diagnosis or detection using three-dimensional analysis
US9303291B2 (en) * 2007-07-06 2016-04-05 The Regents Of The University Of Michigan MIPOL1-ETV1 gene rearrangements
AU2008323649A1 (en) * 2007-11-08 2009-05-14 University Of Washington DNA microarray based identification and mapping of balanced translocation breakpoints

Also Published As

Publication number Publication date
EP3044331B1 (fr) 2020-03-11
WO2015036705A1 (fr) 2015-03-19
CA2923116C (fr) 2022-03-29
US20240417809A1 (en) 2024-12-19
HRP20200747T1 (hr) 2020-10-16
HUE048794T2 (hu) 2020-08-28
CA2923116A1 (fr) 2015-03-19
ES2788652T3 (es) 2020-10-22
FR3010530B1 (fr) 2015-10-09
DK3044331T3 (da) 2020-05-11
US20160319362A1 (en) 2016-11-03
PT3044331T (pt) 2020-05-06
FR3010530A1 (fr) 2015-03-13
EP3044331A1 (fr) 2016-07-20

Similar Documents

Publication Publication Date Title
GB2518057B (en) Tracer and method
IL240276B (en) Method and kit for measuring vitamin d
GB2538371B (en) Well testing and monitoring
SG10201802547YA (en) Method and system for providing recommended terms
IL245602A0 (en) Compositions and methods for evaluating intestinal function
GB201316524D0 (en) Biomarkers
GB201310859D0 (en) Rational method for solubilising proteins
GB201309426D0 (en) Biomarkers
PL3065828T3 (pl) Sposoby i materiały do leczenia złośliwych nowotworów hematologicznych
IL246403A0 (en) Methods and reagents for radioactive labeling
EP3065755A4 (en) Methods for treating hematological malignancies
GB2515495B (en) Permeability determination
GB201308077D0 (en) Biomarkers
GB201306339D0 (en) Biomarkers for prognosis
PT2821771T (pt) Método de teste
HUE048794T2 (hu) Eljárás rosszindulatú hematológiai betegségek diagnosztizálására, és a kapcsolódó készletek
GB201312638D0 (en) Biomarkers
GB201304460D0 (en) Biomarker
IL246069A0 (en) Preparations and methods for the treatment of malignant blood diseases
IL243968A0 (en) Visual indicator test kit
IL243670A0 (en) A method and prognostic kit for monitoring multiple sclerosis
EP2957911A4 (en) Indoxyl SULFATE ANALYSIS PROCEDURE
GB201322783D0 (en) Biomarkers
HUE053185T2 (hu) Szerszámelrendezés
PT3062689T (pt) Método para determinar se o hardware implantado cirúrgicamente deve ser removido